newsfilter
← Latest News
GlobeNewswire·

Statera Biopharma Announces FDA Lifts Clinical Hold on Entolimod

FORT COLLINS, Colo., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the U.S.